No results found for “”
No results found for filter “”
-
Statements & press releases 28.09.26
Commission’s recommendation on health checks important first step towards managing cardiovascular disease...
EFPIA and Vaccines Europe welcome the European Commission’s proposal for a Council Recommendation on cardiovascular health checks.
Read Article -
Statements & press releases 25.09.26
Overweight and obesity linked to 278,000 deaths and the loss of 8 million years of healthy life in 8...
A new study across eight countries in Europe shows that elevated body mass index (BMI) is linked to major health and economic costs each year.
Read Article -
Statements & press releases 18.09.26
EFPIA Statement on the Cloud and AI Development Act (CADA)
EFPIA welcomes the European Commission's proposal for a Regulation establishing a framework of measures to strengthen Europe's cloud and AI ecosystem (Cloud...
Read Article -
Blog articles 18.09.26
Putting people with Alzheimer’s disease at the centre of their healthcare journey
How listening can transform dementia care.
Read Article -
Blog articles 16.09.26
World Patient Safety Day: Safer medicines start long before you take them (Guest blog)
Today, on World Patient Safety Day, we reaffirm that patients are at the center of everything we do.
Read Article -
Blog articles 15.09.26
Alzheimer's disease can't wait: the economic case for Europe to act now (Guest blog)
As we mark World Alzheimer's Month, attention is once again focused on the millions of people across Europe affected by dementia.
Read Article -
Statements & press releases 09.09.26
EFPIA supports progress towards public procurement that rewards quality and innovation
Today’s publication of the European Commission’s proposal for a Public Procurement Act marks an important step towards modernising public procurement across...
Read Article -
Statements & press releases 07.09.26
Patient safety: EAHP & EFPIA publish joint guidance on single unit barcoding
Manufacturers will add barcodes to single doses of medication, helping hospitals reduce dispensation errors and save lives.
Read Article -
Statements & press releases 03.09.26
EFPIA statement on the Advocate General’s Opinion on the Urban Wastewater Treatment Directive
Advocate General recommends annulment of key provisions imposing Extended Producer Responsibility costs on pharmaceutical and cosmetics producers
Read Article -
Statements & press releases 01.09.26
Europe recognised life sciences as a strategic priority. The MFF must now make Europe the place to invest...
EFPIA’s position on the EU Multiannual Financial Framework 2028-2034
Read Article -
Blog articles 03.08.26
Japan's 2026 Honebuto offers a blueprint for Europe's pharmaceutical competitiveness
While Europe continues to debate how to strengthen its competitiveness, Japan is acting.
Read Article -
Blog articles 30.07.26
Know Your Numbers by age 35: A new standard for cardiovascular care in Europe
Investing in well-designed cardiometabolic health checks linked to care pathways would significantly reduce burden of cardiovascular disease in Europe....
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 23.07.26
EFPIA submission to the EU Biotech Act consultation
EFPIA welcomes the European Commission's initiative to develop the Biotech Act and strongly supports its objective of strengthening Europe's life sciences...
Read Article -
EFPIA News 24.06.26
EFPIA and Vaccines Europe (VE) submission to the Call for Evidence for the EU Biotech Act II
EFPIA & VE welcome the European Commission’s initiative to develop the Biotech Act II and supports the objective of strengthening Europe’s industrial biotechnology...
Read Article -
EFPIA News 07.05.26
Why cardiovascular health checks: The case for EU action
A golden opportunity to step up early detection, improve outcomes across the EU, and save costs for health systems and societies.
Read Article -
EFPIA News 27.02.26
Impact of Innovative Medicines/Health Initatives projects on rare diseases
Rare diseases present unique scientific, clinical and economic challenges, and through IMI and IHI public-private partnerships, Europe is building the...
Read Article -
EFPIA News 20.02.26
EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive
The General Court has dismissed EFPIA's action for annulment of the Urban Wastewater Treatment Directive (UWWTD) on the grounds of lack of legal standing. While...
Read Article -
EFPIA News 19.02.26
A comparative analysis of biopharmaceutical strategies in 10 countries
Biopharma is no longer just a health issue. It is a geopolitical and economic priority. In the global race for innovation, countries are investing in biotech...
Read Article -
EFPIA News 15.01.26
Safeguarding intellectual property and trade secrets in the European Health Data Space
EFPIA, MedTech Europe, EUCOPE and COCIR endorse DIGITALEUROPE’s paper “Safeguarding Intellectual Property and Trade Secrets in the European Health Data...
Read Article -
EFPIA News 10.12.25
Advancing Environmental Sustainability Assessment of Pharmaceuticals through Standardisation and Harmonisation...
EFPIA acknowledges the interest in having product environmental data to support climate goals, and member companies are proactively preparing to be able...
Read Article -
EFPIA News 09.12.25
AI Across the Medicines Lifecycle: Insights from Preliminary Case Studies and Considerations for Policy...
As AI becomes more deeply embedded in regulatory decision-making and processes that impact patients, the need for robust governance becomes critical.
Read Article -
EFPIA News 21.10.25
Don’t fall for dupes
Fake medicines are everywhere online, and they’re dangerous. Over 50% of medicines sold online are counterfeit. That’s why EFPIA and TikTok are teaming...
Read Article -
EFPIA News 25.09.25
A Blueprint for Action to address Obesity in the European Union
Obesity is among the most pressing public health challenges of this century and one that is posing a significant burden on Europe’s population and health...
Read Article -
EFPIA News 16.07.25
EFPIA submits GDPR Code of Conduct for formal assessment
EFPIA is pleased to announce the submission of its GDPR Code of Conduct on Clinical Trials and Pharmacovigilance to the Belgian Data Protection Authority...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 28.09.26
Commission’s recommendation on health checks important first step towards managing cardiovascular disease...
EFPIA and Vaccines Europe welcome the European Commission’s proposal for a Council Recommendation on cardiovascular health checks.
Read Article -
Statements & press releases 25.09.26
Overweight and obesity linked to 278,000 deaths and the loss of 8 million years of healthy life in 8...
A new study across eight countries in Europe shows that elevated body mass index (BMI) is linked to major health and economic costs each year.
Read Article -
Statements & press releases 18.09.26
EFPIA Statement on the Cloud and AI Development Act (CADA)
EFPIA welcomes the European Commission's proposal for a Regulation establishing a framework of measures to strengthen Europe's cloud and AI ecosystem (Cloud...
Read Article -
Statements & press releases 09.09.26
EFPIA supports progress towards public procurement that rewards quality and innovation
Today’s publication of the European Commission’s proposal for a Public Procurement Act marks an important step towards modernising public procurement across...
Read Article -
Statements & press releases 07.09.26
Patient safety: EAHP & EFPIA publish joint guidance on single unit barcoding
Manufacturers will add barcodes to single doses of medication, helping hospitals reduce dispensation errors and save lives.
Read Article -
Statements & press releases 03.09.26
EFPIA statement on the Advocate General’s Opinion on the Urban Wastewater Treatment Directive
Advocate General recommends annulment of key provisions imposing Extended Producer Responsibility costs on pharmaceutical and cosmetics producers
Read Article -
Statements & press releases 01.09.26
Europe recognised life sciences as a strategic priority. The MFF must now make Europe the place to invest...
EFPIA’s position on the EU Multiannual Financial Framework 2028-2034
Read Article -
Statements & press releases 14.07.26
EFPIA response to UK Switzerland Free Trade Agreement
A blueprint for life sciences trade.
Read Article -
Statements & press releases 13.07.26
German Parliament passes Statutory Health Insurance Contribution Stabilization Act: EFPIA response
The health reforms passed by the German Parliament send a concerning signal about how Germany values its role as a leader in pharmaceutical innovation...
Read Article -
Statements & press releases 02.07.26
Turning EU excellence in science into commercial success could add more than €120billion to EU economy...
Read the updated report, now expanded to include Japan.
Read Article -
Statements & press releases 25.06.26
EFPIA Reacts to Final EU Approval of EU-US Trade Agreement
While the EU-U.S. agreement brings a degree of certainty for EU-based companies, it is far from an optimal outcome for the sector.
Read Article -
Statements & press releases 23.06.26
Every €1 invested in new medicines returns €5.67 to Europe
Economic study on impact of pharmaceutical innovation in Europe reinforces the argument that under-investment in health is a false economy, costing more...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 18.09.26
Putting people with Alzheimer’s disease at the centre of their healthcare journey
How listening can transform dementia care.
Read Article -
Blog articles 16.09.26
World Patient Safety Day: Safer medicines start long before you take them (Guest blog)
Today, on World Patient Safety Day, we reaffirm that patients are at the center of everything we do.
Read Article -
Blog articles 15.09.26
Alzheimer's disease can't wait: the economic case for Europe to act now (Guest blog)
As we mark World Alzheimer's Month, attention is once again focused on the millions of people across Europe affected by dementia.
Read Article -
Blog articles 03.08.26
Japan's 2026 Honebuto offers a blueprint for Europe's pharmaceutical competitiveness
While Europe continues to debate how to strengthen its competitiveness, Japan is acting.
Read Article -
Blog articles 30.07.26
Know Your Numbers by age 35: A new standard for cardiovascular care in Europe
Investing in well-designed cardiometabolic health checks linked to care pathways would significantly reduce burden of cardiovascular disease in Europe....
Read Article -
Blog articles 25.06.26
Putting the Patient Voice at the Centre of the Health Investment Debate (Guest blog)
FarmaForum organised a dedicated breakfast meeting with patient advocates and representatives of patient organisations. The aim was simple but important:...
Read Article -
Blog articles 18.06.26
Europe has the foundations to lead in biotech – now is the time to build on them
Europe is home to world-class science, talent and healthcare systems. With the right policy environment, it can become a stronger destination for innovative...
Read Article -
Blog articles 08.06.26
Innovation in motion – Europe’s accelerating wave of new cancer medicines (Guest blog)
Over the past three decades, cancer treatment in Europe has entered a new era. One of the clearest signals of this transformation is the accelerating number...
Read Article -
Blog articles 04.06.26
From ambition to implementation: How the pharmaceutical sector is responding to climate change
In just five years, renewable electricity consumption across EFPIA member companies has tripled—a powerful signal of how rapidly climate action is becoming...
Read Article -
Blog articles 02.06.26
Rare Diseases in a changing and competitive Europe
An EU Action Plan on Rare Diseases would offer a coherent framework for improving the lives of millions of people. Here are four areas where industry can...
Read Article -
Blog articles 01.06.26
Bridging the gap: Improving outcomes for children with neurodevelopmental conditions (Guest blog)
Neurodevelopmental conditions such as autism affect up to 10% of people across the EU, as well as their families, friends, and caregivers.
Read Article -
Blog articles 01.06.26
Health is wealth: Slovenia’s Value of Innovation Conference calls for a shift from cost containment to...
Health is no longer only a matter of healthcare systems. It is a foundation of social resilience, economic productivity, competitiveness, and long-term...
Read Article